Pubertal gynecomastia: what about the remaining 10%?

J Pediatr Endocrinol Metab. 2014 Sep;27(9-10):1027-8. doi: 10.1515/jpem-2014-0017.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Estrogen Antagonists / therapeutic use*
  • Gynecomastia / drug therapy*
  • Gynecomastia / physiopathology*
  • Humans
  • Male
  • Tamoxifen / therapeutic use*

Substances

  • Estrogen Antagonists
  • Tamoxifen